Nifty
:
16992.55
Sensex
:
57720.37
47.50 (0.28%)
193.27 (0.34%)
Nifty
Sensex
:
:
16992.55
57720.37
47.50 (0.28%)
193.27 (0.34%)

Alembic Ltd.

Pharmaceuticals & Drugs - API

Rating :
44/99

BSE: 506235 | NSE: ALEMBICLTD

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,510.39
  • 10.46
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,508.55
  • 3.06%
  • 0.62

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.88%
  • 0.49%
  • 19.47%
  • FII
  • DII
  • Others
  • 0.82%
  • 3.89%
  • 4.45%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -8.22
  • -8.99
  • 1.90

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.93
  • 4.68
  • 34.71

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.26
  • 15.58
  • -2.51

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.19
  • 7.05
  • 7.94

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.30
  • 1.12
  • 1.16

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 34.84
  • 36.17
  • 43.23

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Net Sales
30.61
19.15
59.84%
37.42
19.77
89.28%
22.09
21.06
4.89%
18.24
28.89
-36.86%
Expenses
20.17
15.51
30.05%
26.37
16.72
57.72%
16.67
16.75
-0.48%
15.32
24.95
-38.60%
EBITDA
10.44
3.64
186.81%
11.05
3.05
262.30%
5.42
4.31
25.75%
2.92
3.94
-25.89%
EBIDTM
34.11%
19.01%
29.53%
15.43%
24.54%
20.47%
16.01%
13.64%
Other Income
2.44
1.91
27.75%
59.08
81.15
-27.20%
0.70
1.73
-59.54%
4.40
1.77
148.59%
Interest
0.11
0.07
57.14%
0.12
0.12
0.00%
0.11
0.10
10.00%
0.10
0.09
11.11%
Depreciation
1.69
1.18
43.22%
1.67
1.15
45.22%
1.67
1.13
47.79%
1.40
1.03
35.92%
PBT
11.08
4.30
157.67%
68.34
82.93
-17.59%
4.34
4.81
-9.77%
5.82
4.59
26.80%
Tax
0.26
0.19
36.84%
7.09
9.35
-24.17%
0.48
0.97
-50.52%
1.17
0.95
23.16%
PAT
10.82
4.11
163.26%
61.25
73.58
-16.76%
3.86
3.84
0.52%
4.65
3.64
27.75%
PATM
35.35%
21.46%
163.68%
372.18%
17.47%
18.23%
25.49%
12.60%
EPS
1.78
2.02
-11.88%
4.49
4.68
-4.06%
-0.72
1.91
-
0.04
2.80
-98.57%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 10
Mar 09
Net Sales
108.36
78.22
73.52
73.93
123.81
125.30
147.16
127.53
143.95
1,138.14
1,116.07
Net Sales Growth
21.93%
6.39%
-0.55%
-40.29%
-1.19%
-14.85%
15.39%
-11.41%
-87.35%
1.98%
 
Cost Of Goods Sold
6.21
22.62
22.24
12.17
54.07
78.50
96.33
69.67
74.09
572.04
559.08
Gross Profit
102.15
55.60
51.28
61.75
69.74
46.79
50.83
57.86
69.86
566.10
556.99
GP Margin
94.27%
71.08%
69.75%
83.52%
56.33%
37.34%
34.54%
45.37%
48.53%
49.74%
49.91%
Total Expenditure
78.53
64.29
63.09
70.79
105.74
114.22
140.45
121.53
135.35
1,024.55
1,031.58
Power & Fuel Cost
-
0.15
0.42
0.91
2.34
1.11
5.46
13.26
13.30
33.98
38.08
% Of Sales
-
0.19%
0.57%
1.23%
1.89%
0.89%
3.71%
10.40%
9.24%
2.99%
3.41%
Employee Cost
-
21.47
22.60
20.79
20.52
19.64
22.83
23.79
27.00
145.47
131.69
% Of Sales
-
27.45%
30.74%
28.12%
16.57%
15.67%
15.51%
18.65%
18.76%
12.78%
11.80%
Manufacturing Exp.
-
8.30
5.91
25.52
20.00
6.08
7.11
5.77
11.90
91.62
96.22
% Of Sales
-
10.61%
8.04%
34.52%
16.15%
4.85%
4.83%
4.52%
8.27%
8.05%
8.62%
General & Admin Exp.
-
9.12
6.63
8.30
7.15
6.80
6.48
5.30
4.66
76.82
68.22
% Of Sales
-
11.66%
9.02%
11.23%
5.77%
5.43%
4.40%
4.16%
3.24%
6.75%
6.11%
Selling & Distn. Exp.
-
0.69
0.92
0.87
0.11
0.34
0.90
2.11
2.88
92.16
87.12
% Of Sales
-
0.88%
1.25%
1.18%
0.09%
0.27%
0.61%
1.65%
2.00%
8.10%
7.81%
Miscellaneous Exp.
-
1.93
4.37
2.23
1.56
1.75
1.33
1.64
1.51
12.45
87.12
% Of Sales
-
2.47%
5.94%
3.02%
1.26%
1.40%
0.90%
1.29%
1.05%
1.09%
4.59%
EBITDA
29.83
13.93
10.43
3.14
18.07
11.08
6.71
6.00
8.60
113.59
84.49
EBITDA Margin
27.53%
17.81%
14.19%
4.25%
14.59%
8.84%
4.56%
4.70%
5.97%
9.98%
7.57%
Other Income
66.62
89.18
10.92
93.54
29.45
37.04
30.97
28.81
21.73
11.22
15.01
Interest
0.44
0.39
0.36
0.29
0.22
0.17
0.16
0.12
0.83
37.98
52.06
Depreciation
6.43
4.86
3.94
3.23
2.63
3.78
5.09
6.14
6.04
43.02
38.31
PBT
89.58
97.86
17.04
93.17
44.67
44.18
32.44
28.55
23.46
43.81
9.13
Tax
9.00
11.66
3.20
0.13
3.59
2.39
-0.86
0.61
-0.69
4.27
-1.69
Tax Rate
10.05%
11.91%
18.78%
0.14%
8.04%
5.41%
-3.23%
2.41%
-2.94%
9.75%
-18.51%
PAT
80.58
86.19
13.84
93.03
41.08
41.78
27.49
24.72
24.15
39.54
10.82
PAT before Minority Interest
80.58
86.19
13.84
93.03
41.08
41.78
27.49
24.72
24.15
39.54
10.82
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
74.36%
110.19%
18.82%
125.84%
33.18%
33.34%
18.68%
19.38%
16.78%
3.47%
0.97%
PAT Growth
-5.39%
522.76%
-85.12%
126.46%
-1.68%
51.98%
11.21%
2.36%
-38.92%
265.43%
 
EPS
3.14
3.36
0.54
3.62
1.60
1.63
1.07
0.96
0.94
1.54
0.42

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 10
Mar 09
Shareholder's Funds
2,496.58
2,297.03
1,418.04
1,208.53
1,085.77
911.43
803.13
527.81
337.29
331.01
Share Capital
51.36
51.36
51.36
51.36
53.41
53.41
53.41
53.41
26.70
27.44
Total Reserves
2,445.23
2,245.67
1,366.69
1,157.17
1,032.37
858.02
749.72
474.40
310.58
303.57
Non-Current Liabilities
67.60
52.52
6.88
8.52
14.15
12.61
14.69
38.03
422.22
481.85
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
249.31
215.76
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
159.06
259.68
Long Term Provisions
1.10
0.83
0.70
0.72
0.80
0.78
0.64
1.57
0.00
0.00
Current Liabilities
67.76
59.41
45.80
48.80
59.12
68.34
57.68
81.80
269.87
230.03
Trade Payables
19.27
17.81
12.99
24.75
16.42
14.76
16.36
19.19
197.79
169.19
Other Current Liabilities
35.54
30.67
22.07
8.07
31.82
39.20
27.37
26.22
20.42
18.97
Short Term Borrowings
0.00
0.28
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
12.96
10.66
10.74
15.97
10.89
14.38
13.95
36.39
51.66
41.87
Total Liabilities
2,631.94
2,408.96
1,470.72
1,265.85
1,159.04
992.38
875.50
647.64
1,029.38
1,042.89
Net Block
264.15
233.55
209.47
186.88
147.46
147.60
146.42
169.02
393.18
404.78
Gross Block
291.38
256.22
228.24
202.45
160.37
158.33
371.75
402.34
712.34
681.78
Accumulated Depreciation
27.23
22.67
18.78
15.57
12.92
10.73
225.34
233.33
319.15
277.00
Non Current Assets
2,488.63
2,306.87
1,307.90
1,167.08
972.32
801.10
706.29
458.23
405.46
420.29
Capital Work in Progress
33.26
37.27
18.69
22.26
31.64
0.16
0.00
2.47
3.90
7.16
Non Current Investment
2,182.01
2,030.58
1,078.88
957.76
792.85
651.28
558.62
286.52
8.37
8.33
Long Term Loans & Adv.
6.54
1.95
0.86
0.17
0.38
2.05
1.25
0.23
0.00
0.00
Other Non Current Assets
2.67
3.52
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
143.32
102.09
162.82
98.77
186.73
191.28
169.21
189.41
623.91
622.60
Current Investments
25.84
16.59
53.71
43.46
119.85
104.76
46.13
12.23
0.00
0.00
Inventories
86.87
54.28
35.41
35.33
32.41
50.61
74.90
84.31
244.95
238.39
Sundry Debtors
15.22
13.81
8.98
13.51
25.29
21.60
27.98
48.04
192.87
213.00
Cash & Bank
1.85
6.57
58.85
2.01
0.84
2.32
2.34
2.64
23.85
16.41
Other Current Assets
13.54
2.11
1.48
1.88
8.35
11.98
17.87
42.19
162.25
154.81
Short Term Loans & Adv.
9.65
8.73
4.38
2.59
6.34
9.88
16.24
42.19
162.25
154.81
Net Current Assets
75.56
42.68
117.03
49.97
127.61
122.94
111.53
107.61
354.04
392.57
Total Assets
2,631.95
2,408.96
1,470.72
1,265.85
1,159.05
992.38
875.50
647.64
1,029.37
1,042.89

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
-17.75
-2.18
6.54
21.51
23.58
51.63
9.65
149.09
123.09
53.54
PBT
97.86
17.04
93.17
44.67
44.18
26.63
25.33
43.81
16.65
91.05
Adjustment
-78.66
1.65
-85.70
-20.51
-28.85
-20.86
-16.51
73.14
113.95
59.65
Changes in Working Capital
-27.90
-18.64
0.60
1.99
11.89
46.06
1.70
36.16
-4.37
-109.70
Cash after chg. in Working capital
-8.70
0.05
8.06
26.15
27.22
51.83
10.52
153.11
126.23
41.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-9.04
-2.23
-1.53
-4.64
-3.64
-0.20
-0.87
-4.02
-3.13
-3.27
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-6.75
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
18.85
-34.87
56.72
71.67
-22.40
-46.69
-4.76
-23.50
-55.55
-225.13
Net Fixed Assets
-31.14
-42.74
-22.22
-32.70
-33.47
213.26
344.49
-27.30
-61.48
Net Investments
-144.79
-383.89
7.99
70.53
-63.48
-62.37
-141.47
-0.04
5.60
Others
194.78
391.76
70.95
33.84
74.55
-197.58
-207.78
3.84
0.33
Cash from Financing Activity
-5.82
-15.36
-6.41
-92.01
-2.66
-4.96
-5.19
-118.15
-69.79
38.55
Net Cash Inflow / Outflow
-4.72
-52.41
56.85
1.17
-1.48
-0.02
-0.30
7.45
-2.25
-133.05
Opening Cash & Equivalents
5.89
58.30
2.01
0.84
2.32
2.34
2.64
16.41
18.66
151.71
Closing Cash & Equivalent
1.17
5.89
58.85
2.01
0.84
2.32
2.34
23.85
16.41
18.66

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 10
Mar 09
Book Value (Rs.)
97.23
89.45
55.22
47.06
40.66
34.13
30.08
19.77
12.63
12.06
ROA
3.42%
0.71%
6.80%
3.39%
3.88%
2.94%
3.25%
2.88%
3.82%
1.08%
ROE
3.60%
0.75%
7.08%
3.58%
4.18%
3.21%
3.71%
5.58%
11.83%
3.22%
ROCE
4.10%
0.94%
7.12%
3.91%
4.44%
3.12%
3.82%
3.82%
10.54%
7.79%
Fixed Asset Turnover
0.29
0.30
0.34
0.68
0.80
0.58
0.35
0.27
1.65
1.76
Receivable days
67.74
56.58
55.52
57.19
67.34
59.14
103.47
293.96
64.48
71.40
Inventory Days
329.34
222.67
174.64
99.84
119.22
149.70
216.71
401.78
76.79
71.03
Payable days
299.17
252.73
120.48
74.61
55.73
40.49
60.75
331.66
68.63
56.58
Cash Conversion Cycle
97.90
26.52
109.68
82.42
130.83
168.35
259.43
364.08
72.65
85.84
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.21
1.44
Interest Cover
252.50
48.08
324.49
207.64
261.78
169.23
221.26
29.30
2.15
1.18

Annual Reports:

FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011
FY 2010

News Update:


  • Alembic - Quarterly Results
    9th Feb 2023, 17:07 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.